Immunogenetics of ocular inflammatory disease

Tissue Antigens

Volumn 69, Issue 2, 2007, Pages 105-112

  Levinson, R D ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

HLA; Immunogenetics; Uveitis

Indexed keywords

CYTOKINE; HLA ANTIGEN; HLA B27 ANTIGEN; HLA B51 ANTIGEN; HLA DR1 ANTIGEN; HLA DR15 ANTIGEN; HLA DR4 ANTIGEN; INFLIXIMAB; INTERLEUKIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; RETINA ANTIGEN; TUMOR NECROSIS FACTOR;

BEHCET DISEASE; BLAU SYNDROME; BLINDNESS; CD8+ T LYMPHOCYTE; CHORIORETINOPATHY; CHOROIDITIS; CILIARY BODY; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; EYE INFLAMMATION; GENE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOME; GENOTYPE PHENOTYPE CORRELATION; HLA SYSTEM; HUMAN; IMMUNOGENETICS; INTERMEDIATE UVEITIS; INTERSTITIAL NEPHRITIS; IRIDOCYCLITIS; IRIS; IRITIS; JUVENILE RHEUMATOID ARTHRITIS; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR GENE; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RETINA BLOOD VESSEL OCCLUSION; RETINA VASCULITIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; UVEITIS; VISUAL DISORDER; VOGT KOYANAGI SYNDROME;

EYE DISEASES; HLA ANTIGENS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; UVEITIS;

EID: 33846561225     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.00743.x     Document Type: Review

References (57)

1. Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 2004: 111: 491-500.
2. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005: 140: 509-16.
3. Agarwal RK, Caspi RR. Rodent models of experimental autoimmune uveitis. Methods Mol Med 2004: 102: 395-419.
4. Bashirova AA, Martin MP, McVicar DW, Carrington M. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet 2006: 22: 277-300.
5. McCannel CA, Holland GN, Helm CJ et al. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol 1996: 121: 35-46.
6. Martin TM, Zhang G, Luo J et al. A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum 2005: 52: 269-74.
7. Gaudio PA, Kaye DB, Crawford JB. Histopathology of birdshot retinochoroidopathy. Br J Ophthalmol 2002: 86: 1439-41.
8. Shah KH, Levinson RD, Yu F et al. Birdshot chorioretinopathy. Surv Ophthalmol 2005: 50: 519-41.
9. Levinson RD, Park MS, Rikkers SM et al. Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci 2003: 44: 653-7.
10. Linssen A, Rothova A, Valkenburg HA et al. The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27. Invest Ophthalmol Vis Sci 1991: 32: 2568-78.
11. Monnet D, Breban M, Hudry C et al. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology 2004: 111: 802-9.
12. Sampaio-Barros PD, Conde RA, Bonfiglioli R et al. Characterization and outcome of uveitis in 350 patients with spondyloarthropathies. Rheumatol Int 2006: 26: 1143-6.
13. Smith JR. HLA-B27-associated uveitis. Ophthalmol Clin North Am 2002: 15: 297-307.
14. Al Mutawa SA, Hegab SM. Behcet's disease. Clin Exp Med 2004: 4: 103-31.
15. Zierhut M, Mizuki N, Ohno S et al. Immunology and functional genomics of Behcet's disease. Cell Mol Life Sci 2003: 60: 1903-22.
16. Mandeville JT, Levinson RD, Holland GN. The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol 2001: 46: 195-208.
17. Giannini EH, Malagon CN, Van Kerckhove C et al. Longitudinal analysis of HLA associated risks for iridocyclitis in juvenile rheumatoid arthritis. J Rheumatol 1991: 18: 1394-7.
18. Pratsidou-Gertsi P, Kanakoudi-Tsakalidou F, Spyropoulou M et al. Nationwide collaborative study of HLA class II associations with distinct types of juvenile chronic arthritis (JCA) in Greece. Eur J Immunogenet 1999: 26: 299-310.
19. Tang WM, Pulido JS, Eckels DD et al. The association of HLA-DR15 and intermediate uveitis. Am J Ophthalmol 1997: 123: 70-5.
20. Raja SC, Jabs DA, Dunn JP et al. Pars planitis: clinical features and class II HLA associations. Ophthalmology 1999: 106: 594-9.
21. Oruc S, Duffy BF, Mohanakumar T, Kaplan HJ. The association of HLA class II with pars planitis. Am J Ophthalmol 2001: 131: 657-9.
22. Levinson RD, See RF, Rajalingam R et al. HLA-DRB1 and -DQB1 alleles in mestizo patients with Vogt-Koyanagi-Harada's disease in Southern California. Hum Immunol 2004: 65: 1477-82.
23. Monnet D, Brezin AP, Holland GN et al. Longitudinal cohort study of patients with birdshot chorioretinopathy. I. Baseline clinical characteristics. Am J Ophthalmol 2006: 141: 135-42.
24. Rothova A, Berendschot TT, Probst K et al. Birdshot chorioretinopathy; long-term manifestations and visual prognosis. Ophthalmology 2004: 111: 954-9.
25. Rothova A, van Veenedaal WG, Linssen A et al. Clinical features of acute anterior uveitis. Am J Ophthalmol 1987: 103: 137-45.
26. Kilmartin DJ, Wilson D, Liversidge J et al. Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients. Br J Ophthalmol 2001: 85: 281-6.
27. Shindo Y, Ohno S, Usui M et al. Immunogenetic study of sympathetic ophthalmia. Tissue Antigens 1997: 49: 111-5.
28. Islam SM, Numaga J, Matsuki K et al. Influence of HLA-DRB1 gene variation on the clinical course of Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 1994: 35: 752-6.
29. Shindo Y, Ohno S, Yamamoto T et al. Complete association of the HLA-DRB1*04 and -DQB1*04 alleles with Vogt-Koyanagi-Harada's disease. Hum Immunol 1994: 39: 169-76.
30. Shindo Y, Inoko H, Yamamoto T, Ohno S. HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol 1994: 78: 223-6.
31. Desarnaulds AB, Borruat FX, Herbort CP, Spertini F. Multiple evanescent white dot syndrome: a genetic predisposition? Klin Monatsbl Augenheilkd 1996: 208: 301-2.
32. Alaez C, del Pilar MM, Arellanes L et al. Strong association of HLA class II sequences in Mexicans with Vogt-Koyanagi-Harada's disease. Hum Immunol 1999: 60: 875-82.
33. Arellanes-Garcia L, Bautista N, Mora P et al. HLA-DR is strongly associated with Vogt-Koyanagi-Harada disease in Mexican mestizo patients. Ocul Immunol Inflamm 1998: 6: 93-100.
34. Prasad PS, Levinson RD. In silico prediction of binding of putative antigenic peptides to HLA-DRB1 alleles in Vogt-Koyanagi-Harada disease. Clin Immunol 2005: 116: 143-8.
35. Mizuki N, Ota M, Katsuyama Y et al. HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Behcet's disease. Tissue Antigens 2001: 58: 181-4.
36. Mizuki N, Ota M, Katsuyama Y et al. HLA class I genotyping including HLA-B*51 allele typing in the Iranian patients with Behcet's disease. Tissue Antigens 2001: 57: 457-62.
37. Mizuki N, Ota M, Katsuyama Y et al. Sequencing-based typing of HLA-B*51 alleles and the significant association of HLA-B*5101 and -B*5108 with Behcet's disease in Greek patients. Tissue Antigens 2002: 59: 118-21.
38. Levinson RD, Rajalingam R, Park MS et al. Human leukocyte antigen A29 subtypes associated with birdshot retinochoroidopathy. Am J Ophthalmol 2004: 138: 631-4.
39. Donvito B, Monnet D, Tabary T et al. Different HLA class IA region complotypes for HLA-A29.2 and -A29.1 antigens, identical in birdshot retinochoroidopathy patients or healthy individuals. Invest Ophthalmol Vis Sci 2005: 46: 3227-32.
40. Deng L, Mariuzza RA. Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors. Semin Immunol 2006: 18: 159-66.
41. Hughes EH, Collins RW, Kondeatis E et al. Associations of major histocompatibility complex class I chain-related molecule polymorphisms with Behcet's disease in Caucasian patients. Tissue Antigens 2005: 66: 195-9.
42. Kasner L, Chan CC, Whitcup SM, Gery I. The paradoxical effect of tumor necrosis factor alpha (TNF-alpha) in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 1993: 34: 2911-7.
43. Xu H, Rizzo LV, Silver PB, Caspi RR. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Cell Immunol 1997: 178: 69-78.
44. Galor A, Perez VL, Hammel JP, Lowder CY. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Ophthalmology 2006 (e-pub. ahead of print).
45. Ahmad T, Wallace GR, James T et al. Mapping the HLA association in Behcet's disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum 2003: 48: 807-13.
46. Lee EB, Kim JY, Lee YJ et al. TNF and TNF receptor polymorphisms in Korean Behcet's disease patients. Hum Immunol 2003: 64: 614-20.
47. Kuo NW, Lympany PA, Menezo V et al. TNF-857T, a genetic risk marker for acute anterior uveitis. Invest Ophthalmol Vis Sci 2005: 46: 1565-71.
48. Wegscheider BJ, Weger M, Renner W et al. Role of the CCL2/MCP-1- 2518A>G gene polymorphism in HLA-B27 associated uveitis. Mol Vis 2005: 11: 896-900.
49. Stanford MR, Vaughan RW, Kondeatis E et al. Are cytokine gene polymorphisms associated with outcome in patients with idiopathic intermediate uveitis in the United Kingdom? Br J Ophthalmol 2005: 89: 1013-6.
50. Karasneh J, Hajeer AH, Barrett J et al. Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet's disease. Rheumatology (Oxford) 2003: 42: 860-4.
51. Sallakci N, Bacanli A, Coskun M et al. CTLA-4 gene 49A/G polymorphism in Turkish patients with Behcet's disease. Clin Exp Dermatol 2005: 30: 546-50.
52. Chen Y, Vaughan RW, Kondeatis E et al. Chemokine gene polymorphisms associate with gender in patients with uveitis. Tissue Antigens 2004: 63: 41-5.
53. Batioglu F, Atmaca LS, Karabulut HG, Beyza SD. Factor V Leiden and prothrombin gene G20210A mutations in ocular Behcet disease. Acta Ophthalmol Scand 2003: 81: 283-5.
54. Kurokawa T, Kikuchi T, Ohta K et al. Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology 2003: 110: 2040-4.
55. Rose CD, Doyle TM, McIlvain-Simpson G et al. Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis. J Rheumatol 2005: 32: 373-5.
56. Ahmad T, Zhang L, Gogus F et al. CARD15 polymorphisms in Behcet's disease. Scand J Rheumatol 2005: 34: 233-7.
57. Martin TM, Doyle TM, Smith JR et al. Uveitis in patients with sarcoidosis is not associated with mutations in NOD2 (CARD15). Am J Ophthalmol 2003: 136: 933-5.